Filing Flows › Tandem Diabetes Care (TNDM) › Capital expenditures
Tandem Diabetes Care (TNDM) capital expenditures by quarter
Tandem Diabetes Care's capital expenditures were $6.3M in Q1 2026 (first quarter 2026), -6% from Q4 2025. Over the last 3 quarters it ranged from $4.1M (Q3 2025) to $6.7M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | $6.3M | -6% | — |
| Q4 2025 | $6.7M | +63% | — |
| Q3 2025 | $4.1M | — | — |
Q1 2026 at a glance
Tandem Diabetes Care, Q1 2026: revenue $247M (+6% year over year), operating margin -7.1%, net loss $20.4M, operating cash flow $11.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Tandem Diabetes Care's capital expenditures?
Tandem Diabetes Care's capital expenditures were $6.3M in Q1 2026 (first quarter 2026), -6% from Q4 2025.
How has Tandem Diabetes Care's capital expenditures changed?
Over the last 3 quarters it ranged from $4.1M (Q3 2025) to $6.7M (Q4 2025).